Davis Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.5M Sell
9,856
-328
-3% -$76.4K 1.48% 17
2026
Q1
$2.49M Sell
10,184
-385
-4% -$89.7K 1.69% 14
2025
Q4
$2.19M Sell
10,569
-351
-3% -$69.4K 1.51% 16
2025
Q3
$2.02M Buy
+10,920
New +$1.87M 1.4% 19
2025
Q1
$1.75M Buy
10,542
+77
+0.7% +$12K 1.39% 21
2024
Q4
$1.51M Buy
10,465
+33
+0.3% +$5.11K 1.23% 24
2024
Q3
$1.69M Buy
10,432
+441
+4% +$70.3K 1.34% 23
2024
Q2
$1.46M Buy
9,991
+847
+9% +$126K 1.27% 25
2024
Q1
$1.44M Buy
9,144
+531
+6% +$84.5K 1.29% 26
2023
Q4
$1.35M Buy
+8,613
New +$1.32M 1.3% 25
2020
Q2
$980K Sell
6,969
-339
-5% -$49.4K 1.81% 13
2020
Q1
$958K Buy
+7,308
New +$1.04M 2.03% 11

Other funds holding JNJ

Davis Capital Management's JNJ Position: Q2 2026 in Review

Davis Capital Management reduced its Johnson & Johnson (JNJ) stake by 3.2% in Q2 2026, selling an estimated $76.4K and leaving 9,856 shares worth $2.5M. The position accounts for 1.48% of the portfolio, ranked #17.

Davis Capital Management first reported a position in JNJ in Q1 2020 and has held it in 12 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Davis Capital Management held 9,856 shares of Johnson & Johnson worth $2.5M as of Q2 2026.
  • Davis Capital Management sold 328 Johnson & Johnson shares in Q2 2026, an estimated $76.4K.
  • Johnson & Johnson made up 1.48% of Davis Capital Management's portfolio in Q2 2026, its #17 holding.
  • Davis Capital Management first reported a position in Johnson & Johnson in Q1 2020 and has held it in 12 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.